Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-marketing safety surveillance and signal characterization of the novel dissociative steroid Vamorolone in Duchenne muscular dystrophy: a comparative disproportionality analysis based on FAERS data.

Frontiers in pharmacology·2026
Same author

Metabolic reprogramming of cancer associated fibroblasts informs stromal heterogeneity and therapeutic targeting.

Discover oncology·2026
Same author

Performance-Boosted Interpretable ML via Optuna-SHAP: Uncovering Orientation-Driven Twinning in Mg Alloys.

Materials (Basel, Switzerland)·2026
Same author

Post-marketing safety surveillance of the novel muscarinic antipsychotic Xanomeline-Trospium for schizophrenia: A comparative disproportionality analysis against olanzapine based on FAERS data.

Psychiatry research·2026
Same author

Exogenous quorum sensing signal enhances central energy metabolism to fuel biofilm formation and denitrification on microplastics.

Journal of hazardous materials·2026
Same author

Does robotic intersphincteric resection better preserve anal function in low rectal cancer: a systematic review and meta-analysis?

Frontiers in medicine·2026

Related Experiment Video

Updated: May 30, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.0K

Current Development of Mesenchymal Stem Cell-Derived Extracellular Vesicles.

Bingyi Zheng1,2, Xueting Wang1,2, Meizhai Guo1,2

  • 1Cells Good (Xiamen) Inc. Huli, Xiamen Torch Development Zone, Fujian, China.

Cell Transplantation
|January 28, 2025
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) show therapeutic potential via paracrine signaling. This review covers MSC-EV progress, production challenges, and future directions in cell therapy.

Keywords:
extracellular vesiclesimmunomodulatorymesenchymal stem celltissue repair

More Related Videos

A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
09:10

A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells

Published on: June 23, 2022

1.4K
Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
04:54

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs

Published on: May 3, 2024

607

Related Experiment Videos

Last Updated: May 30, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.0K
A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
09:10

A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells

Published on: June 23, 2022

1.4K
Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
04:54

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs

Published on: May 3, 2024

607

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) possess self-renewal and potent immunomodulatory/regenerative properties crucial for cell therapy.
  • Therapeutic effects of MSCs are increasingly attributed to their paracrine products, specifically extracellular vesicles (EVs).
  • MSC-derived EVs (MSC-EVs) carry bioactive molecules like DNA, mRNA, microRNA, and proteins, facilitating intercellular communication.

Purpose of the Study:

  • To review the current advancements in the field of MSC-EVs.
  • To discuss the significant challenges hindering the clinical translation of MSC-EVs.
  • To explore the future prospects and research directions for MSC-EVs in therapy.

Main Methods:

  • Literature review of recent studies on MSC-EVs.
  • Analysis of current research on MSC-EV production and characterization.
  • Discussion of clinical applications and mechanistic insights of MSC-EVs.

Main Results:

  • MSC-EVs are recognized as key mediators of MSC therapeutic benefits.
  • MSC-EVs have demonstrated efficacy in preclinical models for tissue repair and immune disorders.
  • Significant hurdles remain in achieving large-scale MSC-EV production and fully elucidating their mechanisms of action.

Conclusions:

  • MSC-EVs represent a promising cell-free therapeutic strategy with broad clinical potential.
  • Overcoming challenges in scalable production and mechanistic understanding is vital for advancing MSC-EVs.
  • Further research is essential to optimize MSC-EVs for widespread therapeutic applications.